(Q51042780)

English

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

scientific article published on 24 April 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dermatophagoides pteronyssinus

1 reference

based on heuristic

inferred from title

allergic rhinitis

1 reference

based on heuristic

inferred from title

author name string

De-Hui Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Lei Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Lei Cheng

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Ke-Nan Li

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Hu Yuan

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Ji-Hong Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Han Li

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

language of work or name

0 references

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

The Laryngoscope

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

123

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

1334-1340

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Dust mite allergens and asthma—A worldwide problem

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

House dust mite exposure as a cause of asthma

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Allergic rhinitis and asthma: how important is the link?

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Quality of life in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

House dust mite sublingual immunotherapy: results of a US trial

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sublingual immunotherapy: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Immune mechanisms of allergen-specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Patient's compliance with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23935

21 January 2018

Identifiers

10.1002/LARY.23935

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23616386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51042780&oldid=1505059431"